USAQ · XBRL financial data

QHSLab financial statements, every fiscal year

The same tables from 9 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (USAQ's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	125	1,414	1,243	1,409	2,132	2,692
Cost of revenue	74	744	624	615	774	881
Gross profit	50	671	620	794	1,358	1,811
Research and development	98	91	190	214	294	485
General and administrative	132	454	388	259	276	439
Total operating expenses	346	1,173	1,180	1,034	1,152	1,680
Operating income (loss)	(296)	(502)	(561)	(240)	206	131
Interest expense	31	246	433	230	465	237
Income tax expense (benefit)	—	—	0	—	—	—
Net income (loss)	(327)	(770)	(996)	(468)	(259)	457
Earnings per share, basic USD per share	—	(0.10)	(0.11)	(0.05)	(0.03)	0.04
Earnings per share, diluted USD per share	—	—	(0.11)	(0.05)	(0.03)	0.02
Weighted average shares, basic thousands of shares	—	7,861	8,997	9,417	10,288	11,297
Weighted average shares, diluted thousands of shares	—	—	8,997	9,417	10,288	19,342

Fiscal years (USAQ's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	94	287	179	52	157	636
Accounts receivable	61	70	48	71	196	191
Inventory	100	66	52	25	42	36
Prepaid and other current assets	—	23	—	8	26	20
Total current assets	266	446	286	156	421	883
Total assets	298	2,208	1,957	1,681	1,800	2,171
Accounts payable	145	20	86	79	341	326
Total current liabilities	215	875	1,707	2,057	2,407	450
Total liabilities	906	1,384	1,881	2,057	2,407	546
Accumulated deficit	(1,749)	(2,519)	(3,515)	(3,983)	(4,331)	(3,904)
Total stockholders' equity	(608)	824	76	(376)	(608)	1,625
Total liabilities and equity	298	2,208	1,957	1,681	1,800	2,171
Common shares outstanding (cover page) thousands of shares	6,815	8,816	9,316	10,216	11,282	15,033

Fiscal years (USAQ's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(327)	(770)	(996)	(468)	(259)	457
Stock-based compensation	7	36	30	6	0	0
Depreciation and amortization	0	36	128	147	147	91
Net cash from operating activities	(166)	(355)	(351)	(160)	142	178
Net cash from investing activities	(32)	(155)	(37)	—	—	—
Proceeds from issuing common stock	—	30	50	—	—	500
Net cash from financing activities	268	702	280	33	(37)	301
Net change in cash	71	193	(108)	(127)	106	479

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
QHSLab	317	847	(7.8)*	15.0M	40.6 quarters	Q2 FY26 10-QJun 30, 2026
Premier Air Charter Holdings	157	5,784	318*	280.8M	—	Q2 FY26 10-QJun 30, 2026
Vycor Medical	159	418	(4.8)*	33.4M	32.8 quarters	Q2 FY26 10-QJun 30, 2026
Anteris Technologies Global	249,904	1,009	(20,797)*	97.5M	12.0 quarters	Q2 FY26 10-QJun 30, 2026
Profusa	719	not reported	(2,632)*	605,647	0.3 quarters	Q2 FY26 10-QJun 30, 2026
INVO Fertility	3,733	2,175	(1,101)*	2.5M	3.4 quarters	Q2 FY26 10-QJun 30, 2026
LogicMark	3,496	3,349	83*	899,759	—	Q2 FY26 10-QJun 30, 2026
Stimcell Energetics	6.9	not reported	(109)	21.1M	0.1 quarters	Q1 FY27 10-QAug 31, 2026
Bluejay Diagnostics	9,599	not reported	(1,499)*	4.5M	6.4 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.